NCbit Inc. develops hemostasis medical devices, IVD reagents, functional cosmetics and biopharmaceuticals.
NCbit Inc. developed rTLH(Recombinant Trombine-Like Hemocoagulase) the first time ever and applied to the
hemostasis medical devices and IVD reagent for Fibrinogen C test.
NCbit Inc. also develops a antithrombotic and targeted secretion inhibitor.
NCbit Inc. is committed to quality control that is maintained in accordance with regulatory requirements.
We produce high quality products and sell products that meet customer needs in order to contribute to the
development of the national medical device industry.
